Cirio advised Pareto Securities on the deal.Biovica International AB completed the rights issuance of units corresponding to approximately SEK 120 million. Biovica develops and commercializes blood-based…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
